DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME7TXS8

Real-time Bid/Ask 11:44:01 2024-06-05 am EDT
192.75 EUR / 192.83 EUR +0.05% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month+1.12%
1 month+0.13%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-05 192.5 -0.08%
24-06-04 192.7 +0.31%
24-06-03 192.1 +0.80%
24-05-31 190.6 +0.38%
24-05-30 189.8 +0.03%

Delayed Quote Börse Stuttgart

Last update June 05, 2024 at 10:22 am EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7TXS
ISINDE000ME7TXS8
Date issued 2024-01-29
Maturity 2024-12-20 (198 Days)
Parity 1 : 1
Emission price 190.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 194.3
Lowest since issue 185.8
Spread 0.08
Spread %0.04%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
238.5 USD
Average target price
278.7 USD
Spread / Average Target
+16.85%
Consensus